Skip to main content
RecallsAboutBlog

Viatris, Inc.

Viatris, Inc.: 2 recalls listed since April 2026 across FDA.

By year

  • 20262

By agency

  • FDA2

By category

  • Drug2

All recalls (2)

Mylan Telmisartan and Amlodipine Tablets

Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications.

Low risk, FDA, , Wrong drug strength

Viatris Xanax XR Extended-Release Tablets

Xanax XR extended-release tablets failed dissolution specifications.

Moderate risk, FDA, , Drug dissolving problem
Embed this list